Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

ATASOY, BESTE; DANE, FAYSAL; Cetin, I.; Ozgen, Z.; Kefeli, AYŞEGÜL; Ibrahimov, R.; Turhal, N.; Abacioglu, U.; Turkeri, L.

doi:10.1007/s12094-013-1047-8

Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

Copy For Citation

ATASOY B. M., DANE F., Cetin I. A., Ozgen Z., Kefeli A., Ibrahimov R., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.16, no.1, pp.91-95, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 16 Issue: 1
Publication Date: 2014
Doi Number: 10.1007/s12094-013-1047-8
Journal Name: CLINICAL & TRANSLATIONAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.91-95
Keywords: Bladder cancer, Concurrent gemcitabine, Medically unfit patients, Radiotherapy, COMBINED-MODALITY PROGRAM, RADIATION-THERAPY, PHASE-I, NEOADJUVANT CHEMOTHERAPY, ORGAN PRESERVATION, RADIOTHERAPY, TRIAL, CISPLATIN
Kocaeli University Affiliated: No

Abstract

We aimed to determine the efficacy and the toxicity of low dose weekly gemcitabine with radiation therapy in medically unfit muscle-invasive bladder cancer patients.